BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38454166)

  • 21. Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.
    Marquardt V; Theruvath J; Pauck D; Picard D; Qin N; Blümel L; Maue M; Bartl J; Ahmadov U; Langini M; Meyer FD; Cole A; Cruz-Cruz J; Graef CM; Wölfl M; Milde T; Witt O; Erdreich-Epstein A; Leprivier G; Kahlert U; Stefanski A; Stühler K; Keir ST; Bigner DD; Hauer J; Beez T; Knobbe-Thomsen CB; Fischer U; Felsberg J; Hansen FK; Vibhakar R; Venkatraman S; Cheshier SH; Reifenberger G; Borkhardt A; Kurz T; Remke M; Mitra S
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36639156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pirfenidone-loaded exosomes derived from pancreatic ductal adenocarcinoma cells alleviate fibrosis of premetastatic niches to inhibit liver metastasis.
    Zhao J; Zhu Y; Li Z; Liang J; Zhang Y; Zhou S; Zhang Y; Fan Z; Shen Y; Liu Y; Zhang F; Shen S; Xu G; Wang L; Lv Y; Zhang S; Zou X
    Biomater Sci; 2022 Nov; 10(22):6614-6626. PubMed ID: 36260512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes.
    Zheng W; Chen Q; Liu H; Zeng L; Zhou Y; Liu X; Bai Y; Zhang J; Pan Y; Shao C
    Autophagy; 2023 Mar; 19(3):839-857. PubMed ID: 35913916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-peptide attenuates hyperglycemia-induced pulmonary fibrosis by inhibiting transglutaminase 2.
    Jeon HY; Lee AJ; Kim EB; Kim M; Park WS; Ha KS
    J Mol Endocrinol; 2022 Apr; 68(4):209-223. PubMed ID: 35266881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack.
    Wang Z; Moresco P; Yan R; Li J; Gao Y; Biasci D; Yao M; Pearson J; Hechtman JF; Janowitz T; Zaidi RM; Weiss MJ; Fearon DT
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased CFTR/PPARγ and increased transglutaminase 2 in nasal polyps.
    Nguyen TN; Suzuki H; Yoshida Y; Ohkubo JI; Wakasugi T; Kitamura T
    Auris Nasus Larynx; 2022 Dec; 49(6):964-972. PubMed ID: 34728118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LYVE1+ macrophages of murine peritoneal mesothelium promote omentum-independent ovarian tumor growth.
    Zhang N; Kim SH; Gainullina A; Erlich EC; Onufer EJ; Kim J; Czepielewski RS; Helmink BA; Dominguez JR; Saunders BT; Ding J; Williams JW; Jiang JX; Segal BH; Zinselmeyer BH; Randolph GJ; Kim KW
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34714329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis.
    Lee B; Namkoong H; Yang Y; Huang H; Heller D; Szot GL; Davis MM; Husain SZ; Pandol SJ; Bellin MD; Habtezion A
    Gut; 2022 Sep; 71(9):1831-1842. PubMed ID: 34702715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1.
    Xi Y; Li Y; Xu P; Li S; Liu Z; Tung HC; Cai X; Wang J; Huang H; Wang M; Xu M; Ren S; Li S; Zhang M; Lee YJ; Huang L; Yang D; He J; Huang Z; Xie W
    Sci Adv; 2021 Sep; 7(36):eabg9241. PubMed ID: 34516906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.
    Lewis GA; Dodd S; Clayton D; Bedson E; Eccleson H; Schelbert EB; Naish JH; Jimenez BD; Williams SG; Cunnington C; Ahmed FZ; Cooper A; Rajavarma Viswesvaraiah ; Russell S; McDonagh T; Williamson PR; Miller CA
    Nat Med; 2021 Aug; 27(8):1477-1482. PubMed ID: 34385704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
    Laurent P; Allard B; Manicki P; Jolivel V; Levionnois E; Jeljeli M; Henrot P; Izotte J; Leleu D; Groppi A; Seneschal J; Constans J; Chizzolini C; Richez C; Duffau P; Lazaro E; Forcade E; Schaeverbeke T; Pradeu T; Batteux F; Blanco P; Contin-Bordes C; Truchetet ME
    Ann Rheum Dis; 2021 Dec; 80(12):1594-1603. PubMed ID: 34285051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer.
    Koltai T; Reshkin SJ; Carvalho TMA; Cardone RA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
    Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
    BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The war against pancreatic cancer in 2020 - advances on all fronts.
    Jain T; Dudeja V
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):99-100. PubMed ID: 33414515
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.
    Yu J; Green MD; Li S; Sun Y; Journey SN; Choi JE; Rizvi SM; Qin A; Waninger JJ; Lang X; Chopra Z; El Naqa I; Zhou J; Bian Y; Jiang L; Tezel A; Skvarce J; Achar RK; Sitto M; Rosen BS; Su F; Narayanan SP; Cao X; Wei S; Szeliga W; Vatan L; Mayo C; Morgan MA; Schonewolf CA; Cuneo K; Kryczek I; Ma VT; Lao CD; Lawrence TS; Ramnath N; Wen F; Chinnaiyan AM; Cieslik M; Alva A; Zou W
    Nat Med; 2021 Jan; 27(1):152-164. PubMed ID: 33398162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine.
    Xavier CPR; Castro I; Caires HR; Ferreira D; Cavadas B; Pereira L; Santos LL; Oliveira MJ; Vasconcelos MH
    Cancer Lett; 2021 Mar; 501():210-223. PubMed ID: 33212158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer.
    Kocher HM; Basu B; Froeling FEM; Sarker D; Slater S; Carlin D; deSouza NM; De Paepe KN; Goulart MR; Hughes C; Imrali A; Roberts R; Pawula M; Houghton R; Lawrence C; Yogeswaran Y; Mousa K; Coetzee C; Sasieni P; Prendergast A; Propper DJ
    Nat Commun; 2020 Sep; 11(1):4841. PubMed ID: 32973176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic cancer stroma: an update on therapeutic targeting strategies.
    Hosein AN; Brekken RA; Maitra A
    Nat Rev Gastroenterol Hepatol; 2020 Aug; 17(8):487-505. PubMed ID: 32393771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer.
    Ramakrishnan P; Loh WM; Gopinath SCB; Bonam SR; Fareez IM; Mac Guad R; Sim MS; Wu YS
    Acta Pharm Sin B; 2020 Mar; 10(3):399-413. PubMed ID: 32140388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches.
    Chakarov S; Lim HY; Tan L; Lim SY; See P; Lum J; Zhang XM; Foo S; Nakamizo S; Duan K; Kong WT; Gentek R; Balachander A; Carbajo D; Bleriot C; Malleret B; Tam JKC; Baig S; Shabeer M; Toh SES; Schlitzer A; Larbi A; Marichal T; Malissen B; Chen J; Poidinger M; Kabashima K; Bajenoff M; Ng LG; Angeli V; Ginhoux F
    Science; 2019 Mar; 363(6432):. PubMed ID: 30872492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.